🔗 Share this article

An underground economy for unapproved weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, based on new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also receiving discount codes.

Active Trade on Social Networks

Additionally, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and claims of next-day British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in individuals injecting products of unknown origin.

Some professionals stated the demand for the experimental drug could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Response and Material Removal

According to the social media company, the service has taken down problematic content and prohibited associated hashtags and search suggestions. The company stated it was committed to maintaining the platform secure and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, filled with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at residence.

Within moments of joining one group, a vendor posted WhatsApp details, where the majority of purchases take place. The seller sent an guidebook and promised delivery within two days. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Item Details and Costs

Within these groups, posts display black plastic packages with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors typically sold at £160 for 20mg. When asked how much time a injector should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it regularly moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting materials they can’t verify. Although the science behind this drug is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has already seen individuals injured by personal administration from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose patients to possibly significant medical dangers”.